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Abstract
Background: Cancer Related Fatigue (CRF) and circadian rhythm have a great impact on the quality of life (HRQL)
of patients with breast (BC) and colon cancer (CRC). Other patient related outcomes in oncology are measured by
new instruments focusing on adaptive characteristics such as sense of coherence or self-regulation, which could be
more appropriate as a prognostic tool than classical HRQL. The aim of this study was to assess the association of
autonomic regulation (aR) and self-regulation (SR) with survival.
Methods: 146 cancer patients and 120 healthy controls took part in an initial evaluation in 2000/2001. At a median
follow up of 5.9 years later, 62 of 95 BC, 17 of 51 CRC patients, and 85 of 117 healthy controls took part in the
follow-up study. 41 participants had died. For the follow-up evaluation, participants were requested to complete
the standardized aR and SR questionnaires.
Results: On average, cancer patients had survived for 10.1 years with the disease. Using a Cox proportional hazard
regression with stepwise variables such as age, diagnosis group, Charlson co-morbidity index, body mass index
(BMI)) aR and SR. SR were identified as independent parameters with potential prognostic relevance on survival
While aR did not significantly influence survival, SR showed a positive and independent impact on survival (OR =
0.589; 95%-CI: 0.354 - 0.979). This positive effect persisted significantly in the sensitivity analysis of the subgroup of
tumour patients and in the subscale ‘Achieve satisfaction and well-being’ and by tendency in the UICC stages
nested for the different diagnoses groups.
Conclusions: Self-regulation might be an independent prognostic factor for the survival of breast and colon
carcinoma patients and merits further prospective studies.
Keywords: Autonomic regulation (aR), breast cancer, colorectal cancer, coping, self-regulation (SR)
Background
Cancer Related Fatigue (CRF) is one of the most com-
mon symptoms experienced by cancer patients receiving
palliative care [1] and patients treated with chemo- or
radiotherapy [2]; it is also relatively common in disease-
free cancer patients. In a British study 58% of all
oncology outpatients reported that fatigue affected them
‘somewhat or very much’ and described it as the most
important symptom which is often not being well-mana-
ged [3].
CRF is often associated with sleep disturbances. From
the 31% of all cancer patients suffering from insomnia
in a large cross sectional study, 76% reported disturbed
sleep continuation [4] Disturbed rest/activity and
affected circadian rhythms may aggravate CRF and
depressive symptoms in adjuvant treated breast cancer
patients [5] and diminishes health-related quality of life
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In metastasized colon carcinoma patients actimetrically
measured disturbed rest/activity rhythm is associated
with shorter survival [7] and in breast cancer patients
(BC) diminished circadian cortisol rhythm is associated
with higher mortality [8]. Beside physiological measures,
another epidemiological available approach is measuring
rest/activity regulation with a validated assessment
applicable in clinical settings as a part of a questionnaire
measuring different functions (1. rest/activity, 2. ortho-
static-circulatory, 3. digestion) of autonomic regulation
(aR), which to our knowledge is the first scale measuring
autonomic functioning with sufficient validity [9].
There is some evidence that questionnaires measuring
patients’ adaptive capacity towards disease and health-
orientated life-style change, such as the ‘sense of coher-
ence’ (SOC) [10] or ‘self-regulation’ (SR) [11], could
have stronger association with prognosis in oncology or
other chronic conditions than HRQL scales [12-15].
O n eo ft h e s et o o l si sb a s e do nA n t o n o v s k y ’sc o r eq u e s -
tion ‘What may keep one healthy?’ For Antonovsky,
SOC is based on three components which are prerequi-
sites for salutogenesis, i.e., comprehensibility, meaning-
fulness, and manageability [10]. Up to now, inventories
which capture the SOC based on Antonovsky’sc o n c e p t
of salutogenesis are predominantly validated for patients
with psychosomatic or mental health conditions, psy-
chiatric patients. Moreover, they are often used in socio-
logical studies as a stable personality trait marker, while
they have not been developed as clinical measures for
physical and oncological conditions [10,16-18].
Another scale based on salutogenesis with a clinical
application is the psychosomatic Self-Regulation Scale
(SR) developed by Grossarth-Maticek. This question-
naire deals with the “ability to actively achieve well-
being, inner equilibrium, appropriate stimulation, a feel-
ing of competence, and a sense of being able to control
stressful situations” [19]. Grossarth-Maticek & Eysenck
characterized this concept as a short-hand personality
trait term which “covers a conglomerate of concepts”
related to reaction to a variety of stressors and coping
mechanisms and not only as ‘locus of control’ [15]. The
SR scale has been developed as an epidemiological, pre-
ventive health care and clinical measure in a long and
short version, and has been validated, applied and evalu-
ated against physical risk factors prospectively in breast
and colorectal cancer patients [11,14]. SR short version
is capturing two factors: 1) ability to ‘change behaviour
to reach a goal’ and 2) a subscale called ‘Achieve satis-
faction and well-being’ [20].
The aim of our study was to assess the influence on
overall survival of
1) the validated autonomic regulation scale (aR) (and
its subscale for rest/activity rhythm (R/A.aR)) [9] and of
2) the short version of the psychosomatic Self-Regula-
tion Scale (SR) (and its subscales ‘Change behaviour to
reach goal’ and ‘Achieve satisfaction and well-being’)
[20].
Methods
Patients
This multicenter observational study was conducted at
the Department of Internal Medicine, Surgery and
Gynaecology of the Havelhöhe Community Hospital,
Berlin, the Öschelbronn Oncological Practice and the
Wuppertal Endocrinology Practice from April 2000 -
November 2001. The participants of the study consisted
of healthy volunteers and in total seven groups of
patients. The latter were recruited consecutively among
inpatients at the Havelhöhe Hospital and from outpati-
ents in the two practises. In this paper we report the
results from the breast cancer and colorectal cancer
group and the healthy controls.
The inclusion criterion was histologically proven
breast or colorectal cancer. The control group was
recruited from the Havelhöhe Hospital staff and their
relatives. Exclusion criteria were other severe organic
diseases, manifest psychosis, severe immobilisation or a
Karnofsky index (KPI) < 50%, uncontrolled pain, recent
operations (< 1 week prior to study recruitment) and
recent chemo- or radiotherapy (< 3 weeks prior recruit-
ment). Among 131 healthy volunteers, 95 breast cancer
(all female) patients and 51 colorectal cancer patients
(30 female/58.8%), all cancer patients and 120 healthy
controls (80 female/66.7%) (C) gave their written con-
sent and took part in an initial evaluation in 2000/2001
(table 1). According to our institutional standard in
2000, we did not ask ethical approval in anonymous
questionnaire based observational studies.
From April 2006 to October 2007 we conducted a re-
assessment of all participants of the 2000-2001 study.
After checking our medical patients documents we
checked than if participants were still registered with
the local administration; if they were no longer regis-
tered we investigated whether they had died (registered
death date) or moved. (Figure 1, table 1).
Measures
Participants were given the aR-scale (table 2), the SR
scale (table 3) and the Hospital Anxiety and Depression
Scale (HADS) [21] in 2000/2001 and 2006/2007, and a
self-completion version of the Karnofsky index (KPI).
1) The autonomic regulation (aR) scale addresses the
state of regulation of different autonomic functions. The
18-item scale measures the three factor model Ortho-
static-Circulatory, Rest/Activity and Digestive regulation
with a three-point Likert scale and has a satisfying inter-
nal consistency (Cronbach-a:r a = 0.65-0.75), and
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Page 2 of 11Table 1 Sociodemographic data of the study groups including stage, therapies, participation rate
in 2000-2001 in 2006-2007
CG BC CRC CG BC CRC
Died 2 14 25
Invited (n): 131 95 51 117 81 26
Consented (n): 120 95 51 85 62 17
Complete Data (n): 115 95 49
Censored Data 74 1
Women (n): 80 95 30
Age (mean): 54 57.1 62
(SD) (14.2) (9.9) (12.2)
Marital Status:
Married (n/%) 75/65.2 59/62.1 33/67.3
Single (n/%) 13/11.3 8/8.4 6/12.2
Divorced (n/%) 15/13.0 13/13.7 5/10.2
Widowed (n/%) 8/7.0 9/9.5 4/8.2
No details available (n/%) 4/3.4 6/6.3 1/2.0
Most recent profession:
Worker (n/%) 6/5.2 12/12.6 12/24.4
Employee/civil servant (n/%) 72/62.6 45/47.4 22/44.9
Self employed (n/%) 19/16.5 8/8.4 5/10.2
House wife/husband (n/%) 12/10.4 23/24.2 10/20.4
Still in education (n/%) 3/2.6 0/0 0/0
No details available (n/%) 3/2.6 7/7.3 0/0
Pension (n/%)
Karnofsky-I. %(SD) of survivors: 96.7(7.2) 88.2(12.5)
UICC stages (n/%):
I 28/29.5 6/12
II 37/38.9 9/18
I/II 3/3.2 -
III 4/4.2 15/29
II/III - 2/4
IV 23/24.2 19/37
Grading (SD): 2.0(0.62) 2.25(0.51)
Metastasis localisation (n/%):
Bone 5/5.2 1/1.9
Liver - 8/15.7
Peritoneal - 2/3.9
Lung 2/2.1 -
Multiple 9/9.4 7/13.7
others 5/5.2 1/1.9
Duration of disease (Mean/SD): 4.7/5.6 1.7/2.3
Menopausal status at diagnosis:
Premenopausal (n/%) 38/39.6
Postmenopausal (n/%) 53/55.2
Treatment:
Operation: n/% 93/97.9 51/100
Chemotherapy: n/% 55/57.9 22/44
Radiotherapy: n/% 55/57.9 8/15.7
antihormonal therapy.: n/% 55/57.9 -
mistletoe therapy: n/% 79/83.2 38/71.7
Abbreviations: control group (CG), breast cancer (BC), colorectal cancer (CRC)
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Page 3 of 11satisfying to good test-retest reliability (rrt = 0.70 - 85),
and good validity [9].
2) The short questionnaire on self-regulation (SR) is
a scale with 16 items to measure one’sa c t i v i t yt o w a r d s
harmonizing and health orientation with a six-point
Likert scale ranging from 1 (very weak) to 6 (very
strong) (addition of the 16 items and division by 16:
Range 1-6. The questionnaire consists of two subscales
with eight items each: 1) ‘Change behaviour to reach
goal’ and 2) ‘Achieve satisfaction and well-being’. Higher
scoring indicates better self-regulation. The self-regula-
tion questionnaire is highly reliable and valid with a
good - very good internal consistency (Cronbach-a:r a
= 0.80-0.95) and satisfying - good test-retest reliability =
0.73-0.82) [11,20].
3) The Karnofsky performance index (KPI) is a com-
monly used functional measure for oncology patients
[22]. Although it was designed for clinical assessment by
physicians, its categorization is easy to understand for
patients as well and was thus be used for a patient-
based evaluation.
4) The German version of the ‘Hospital Anxiety and
Depression Scale’ (HADS-D) consists of 14 items (7 for
anxiety and 7 for depression) with a four-point Likert
scale (0-21 for both). Higher scoring indicates more
symptoms. The HADS is highly reliable and valid and is
an extensively used scale in internal medicine research
[21].
5) The Charlson co-morbidity index is an often used
index in internal medicine and oncology for co-morbid-
ity with a robust correlation with outcome [23].
Statistical analysis
Analysis was performed with SPSS 16.0 and SAS 9.1.3
software packages. Relevant factors influencing survival
were identified by a variable selection procedure using
Cox proportional hazard regression. Parameters
included in the selection process as independent factors
included diagnostic groups, age, sex, Charlson co-mor-
bidity index, nicotine abuse, body mass index (BMI),
anxiety and depression scores of the HADS, allergy and
marital status, aR and SRS. Primary variable selection
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Figure 1 Flow chart of participants recruiting 2000/2001 and 2006/2007.
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Page 4 of 11Table 2 Items on autonomic regulation
Questions autonomic regulation Possible answers
On autonomic regulation
Low = 1 average = 2 high = 3
Orthostatic-circulatory regulation
Do you suffer from dizzy spells? frequently occasionally never
Do you suffer from dizziness when you look down from a height? frequently occasionally never
Do you suffer from dizziness when you get up in the morning? frequently occasionally never
Do you suffer from dizziness when you straighten up or bend down? frequently occasionally never
Do you tend to have cold or cold-sweaty hands even in the warmer months? frequently occasionally rarely
Do you suffer from travel sickness (e.g. sea sickness)? frequently occasionally almost
Do you get dizzy from circular motions (when on a roundabout, for example)? frequently occasionally almost
Rest/activity regulation
Do you have to pull yourself together to go to work? frequently occasionally rarely
Do you feel rested in the morning rarely occasionally frequently
Do you have problems falling asleep? frequently occasionally rarely
Do you tend to sweat? frequently occasionally rarely
Do you suffer from disturbed sleep? frequently occasionally rarely
At what time of the day do you feel most comfortable? evening in the middle of the day morning
Do you tend to sweat at night? frequently occasionally rarely
Do you tend to have stomach growling? frequently occasionally rarely
Digestive regulation
How often do you have bowel movements? < 1/day approx. 1/day > 1/day
Do you normally have bowel movements at regular times? rarely occasionally frequently
Do you suffer from constipation? frequently occasionally rarely
18 item sum scale
18 validated items on autonomic regulation with the three subscales orthostatic-circulatory, rest/activity and digestive regulation, including the individual,
possible answers. The left answer corresponds to low (1 point), the middle to average (2 points) and the right to high autonomic regulation (3 points).
Table 3 Items of the self-regulation questionnaire with the two subscales 1) Ability to Change Behaviour in Order to
Reach Goals and 2) Achieve Satisfaction and Well-Being
Questionnaire on Self-regulation
1. Ability to Change Behaviour in Order to Reach Goals
SR12 Ability for new behaviour pattern
SR11 Ability to change behaviour to reach pleasant outcome
SR6 Threatening situations: behave to emerge safe
SR10 Find standpoints/behaviour pattern which allow pleasant problem solving
SR7 Attain most important objectives
SR9 Disappointment: no reason for resignation, but cause to change behaviour
SR13 Because of behaviour desired proximity and required distance to important others
SR4 Expand various activities until states change to total satisfaction
2. Achieve Satisfaction and Well-Being
SR15 Achieve well-being by daily activities
SR14 Activate inner satisfaction over and over again by daily activities
SR2 Actualize wishes and satisfy needs
SR5 arrange different areas of life optimal so that well-being can result
SR3 Achieve situations/states which restore well-being
SR1 Achieve situations/states which motivate
SR8 Achieve situations/states which satisfy wishes and needs optimal
SR16 Behaviour gives rise to situations which cause experiences full of relish
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Page 5 of 11was a stepwise selection procedure, a combination of
forward and backward variable selection. This procedure
computed the score statistic for each effect not yet in
the model. The parameter with the largest of these
score statistics, when significant at an error level of 0.25,
was added to the model. Any parameter could again be
removed from the selected variables model if its p-value
increased over a threshold of 0.15 after inclusion or
removal of other parameters. The outcome of the step-
wise selection was compared with pure forward and
backward selection techniques. All procedures resulted
in the same parameters remaining in the model. This
consistency in parameter selection was also the case in
the sensitivity analyses.
The proportionality assumption of the selected model
was checked by a resample Kolmogorov supremum test
with 1000 simulation iterations as suggested by Lin et
a l .[ 2 4 ] .H e r e ,a g et u r n e do u tt os i g n i f i c a n t l yd e v i a t e
from proportionality assumptions. After graphical
inspection, age was squared for inclusion. Thereby not
only the non-proportionality of this parameter was
resolved but the Cox model resulted in smaller p-values
for all other parameters except for BMI.
Because of differences in prognosis between both can-
cer groups, stage according to Union Internationale
Contre le Cancer (UICC), nested in the different diag-
nostic groups, was integrated in a sensitivity analysis
(healthy subjects were allocated to UICC stage 0).
Further sensitivity analyses regarded only the sub-group
of tumor patients, with and without additionally includ-
ing tumor and lymph node staging, presence of metas-
tases, grading, and the use of chemo-, radio- or
mistletoe therapy in the parameter selection process. An
analysis aiming to include both UICC staging and tumor
patient sub-sample failed to result in a reliable model
estimate due to an insufficient number of events.
In order to illustrate the influence of SRS for all diag-
nosis groups, in a Kaplan-Meier survival plot we allo-
cated all patients at a SRS of 3.85 (which is a clinical
useful cut-off between moderate and good SRS) into a
high SRS (> 3.85) or low SRS (< 3.85) class, respectively.
Results
At study inclusion breast cancer patients participating in
the study had a mean disease duration of 4.7 years, 13
(13.7%) of them a disease duration of less than 1 year,
only 3 (3.2%) an operation between 2 and 4 weeks
before. About half the participants were postmenopausal
at diagnosis (55.2%) and 75.8% (4.2% in UICC 3) did not
have metastatic disease stage. 97.9% had been operated
and 57.9% of all had received standard radio-chemother-
apy and were still receiving hormonal treatment (table
1). Colorectal cancer patients participating in the study
had a mean disease duration of 1.7 years, 23 (45.1%) of
them a disease duration of less than 1 year, 13 (25.5%)
in the last month. Only 63% did not have metastatic dis-
ease (29% UICC 3). 44% had received chemotherapy and
15.7% radiotherapy (table 1). Both groups had a high
rate of concomitant mistletoe therapy (83.2% and 71.7%)
(table 1).
With a median follow up of 5.9 years, 62 of 81 breast
cancer patients (BC), 17 of 26 colorectal cancer patients
(CRC), and 85 of 117 controls (C) (in total 73.2%) parti-
cipated in the follow-up study (equivalent to 61.6% of
the initial sample). From the initial cohort, 41 of 266
participants (14 BC, 25 CRC, 2 C) had died (15.4%),
with 77.1% of patients of the entire initial cohort (table
1) responding (table 1). Mean survival time of the can-
cer groups was 10.1 years (SD = 3.9). Mean age of the
whole group was 60.2 years (SD = 12.2); for details of
the study groups refer to table 1.
The Karnofsky performance index (KPI) of the cancer
survivors was 96.7% (all 92.5%) in breast cancer and
88.2% in colorectal cancer (all 83.3%) at baseline. AR
sum scale correlates with SR initially with r = 0.34.
There were three bivariate correlations within these
variables above 0.5, with the highest value of 0.62
between the anxiety and the depression scale of the
HADS and KPI with diagnosis and UICC stage (-0.53–
0.61); thus, multi-collinearity was of no concern, as was
confirmed by ridge analysis. Nevertheless, KPI was not
integrated in the stepwise variable selection because of
its moderate to strong correlation with diagnosis and
UICC stage.
In the final model after variables selection the diagno-
sis groups colorectal carcinoma (HR = 23.515, CI =
5.183-106.683, p < 0.0001 and breast cancer (HR =
5.244, CI = 1.111-24.757, p = 0.0364), the Charlson co-
morbidity index (HR = 1.389, CI = 1.043-1.848, p =
0.0245) and high self-regulation show positive and inde-
pendent impact on survival, with an HR of 0.589 (95%-
CI: 0.354-0.979) (table 4). This positive effect is corrobo-
rated by the analysis of the two subscales for ‘Achieve
satisfaction and well-being’ (HR = 0.560; 95%-CI: 0.350-
0.895) and by tendency for ‘Change behaviour to reach
goal’ (HR = 0.663; 95%-CI: 0.413-1.066). On the other
hand aR sum scale and rest/activity regulation subscale
(R/A.aR) have no significant influence on survival (aR:
HR = 1.069, CI = 0.992-1.152; R/A.aR: HR = 1.069,
0.948-1.205).
We conducted a second stepwise variables selection
limited to the two cancer groups with the above used
candidates and included chemotherapy, radiotherapy,
mistletoe therapy, metastases (yes/no), grading (1-3). In
the final model entered the following candidates: diag-
nosis colorectal cancer (HR = 22.106, CI = 5.404-
90.424), metastasis (HR = 25.954, CI = 7.558-89.128),
grading (HR = 0.179, CI = 0.072-0.446), age (HR =
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Page 6 of 111.610, CI = 1.037-2.498) and self-regulation (HR =
0.426, CI = 0.184-0.985) (table 5).
The sensitivity analysis, with nested UICC stages for
both cancer groups, clearly resulted in a reduction in
the parameters age and Charlson co-morbidity index,
even if these variables were only moderately correlated
with UICC stage (0.17 and 0.16, respectively). Estimates
of SRS, on the other hand, were nearly unaffected in
this model (HR = 0.565, 95%-CI: 0.306-1.045) but failed
the 5% threshold (p = 0.0686) because of decrease sam-
ple number and consecutive increasing confidence inter-
val (table 6). In the Kaplan Meier survival plot,
colorectal cancer patients with low SR had the highest
mortality, followed by the CRC-patients with high SR
and breast cancer patients with low SR and high SR
(Figure 2).
Discussion
In this study we found that, in addition to diagnostic
group, UICC stages and the Charlson co-morbidity
index, the self regulation (SR) scale (in particular its
subscales ‘Achieve satisfaction and well-being)’ was a
significant independent positive predictor of survival of
breast and colorectal cancer patients. The autonomic
regulation (aR) scale had no significant prognostic value.
Our findings on self-regulation are consistent with
results of another research group that found that self-
regulation is positively associated with patients survival
with a range of solid tumours [11,19]. Self-Regulation
(SR) is thought to represent the “ability to actively
achieve well-being, inner equilibrium, appropriate stimu-
lation and feeling of competence to control and manage
stressful situations”[20] and shows repeatedly low-mod-
erate correlations with aR (0.30-0.38) [25,20]. Unpub-
lished data from our study group show a strong
correlation between SR and the three SOC-subscales
(comprehensibility, manageability and meaningfulness)
from r = 0.70 to 0.73 (p < 0.05) which suggest that
SOC/resilience might be connected with a goal-orien-
tated change of lifestyle and orientation towards well-
being. Gender specific coping strategies have been
articulated, with women using a more emotion-based
and men a more problem-orientated strategy. This dis-
tinction corresponds to the two subscales of self-regula-
tion and the stronger relationship of “well-being
orientation” to prognosis could be a function of our pre-
dominantly female sample [26]. Frentzel-Beyme & Gros-
sarth hypothesized that highly self-regulated persons are
more capable coping with sources of uncertainty and
instability. The authors assume that people with well-
regulated behaviour have a psycho-neuro-physiological
basis for better competence and defence against health
hazards [27]. The actual mechanism for the interaction
of self-regulation and SOC with physiological processes
Table 4 Final model after variable selection for breast and colorectal cancer and control group, significant results are
printed in bold
Parameter DF Parameter Estimate Standard Error Chi-Square P value Hazard-Ratio 95% Hazard Ratio Confidence
Limits
Diagnosis-group
Colon-CA
1 3.15763 0.77156 16.7488 < .0001 23.515 5.183 106.683
Diagnosis-group
breast-CA
1 1.65702 0.79189 4.3785 0.0364 5.244 1.111 24.757
Age, Hazard Rate/10 years 1 0.33779 0.18621 3.2906 0.0697 1.402 0.973 2.019
Charlson Comorbidity Index 1 0.32824 0.14593 5.0593 0.0245 1.389 1.043 1.848
BMI to day 1 -0.08717 0.05667 2.3658 0.1240 0.917 0.820 1.024
aR score 1 0.06639 0.03810 3.0368 0.0814 1.069 0.992 1.152
Self-regulation-Score 1 -0.52945 0.25945 4.1645 0.0413 0.589 0.354 0.979
Table 5 Final model after variable selection for breast and colorectal cancer, significant results are printed in bold
Analysis of Maximum Likelihood Estimates
Parameter DF Parameter
Estimate
Standard
Error
Chi-Square p-value Hazard
Ratio
95% Hazard Ratio Confidence Limits
Diagnosis-Group Colorectal-cancer 1 3.09583 0.71873 18.5535 < .0001 22.106 5.404 90.424
Age 1 0.47614 0.22422 4.5094 0.0337 1.610 1.037 2.498
Body mass-index 1 -0.13025 0.07652 2.8972 0.0887 0.878 0.756 1.020
Trait aR-score 1 0.09607 0.05278 3.3127 0.0687 1.101 0.993 1.221
Self-regulation-Score 1 -0.85285 0.42751 3.9797 0.0461 0.426 0.184 0.985
Grading 1 -1.71907 0.46490 13.6731 0.0002 0.179 0.072 0.446
Metastases 1 3.25634 0.62947 26.7612 < .0001 25.954 7.558 89.128
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Page 7 of 11remains unclear [28]. Both cross-sectional and prospec-
tive data show a positive association of the SOC scale to
cancer survival and lower cancer incidence that are con-
sistent with our results [13,29] if this depends on a
higher resilience towards social stress, and a higher abil-
ity to adapt remains unclear [30]. However, this match
with data from the self-regulation scale that autonomy
helps for better stress management, less neuroticsm,
better HRQL and initiative power and could be there-
fore helpful tool in preventive medicine [14,20].
Our findings support the case for developing interven-
tions to improve self-regulation in cancer patients.
Table 6 Sensitivity analysis, final model after variable selection and UICC stages instead of diagnosis classes,
significant results are plotted in bold
Parameter stage DF Parameter
Estimate
Standard
Error
Chi-Square P value Hazard
Ratio
95% Hazard Ratio Confidence Limits
Age (per 10 years) 1 0.36142 0.18408 3.8549 0.0496 1.435 1.001 2.059
Charlson index 1 0.19521 0.13789 2.0042 0.1569 1.216 0.928 1.593
BMI_to day 1 -0.06812 0.05129 1.7636 0.1842 0.934 0.845 1.033
aR score 1 0.06235 0.04595 1.8414 0.1748 1.064 0.973 1.165
Self-regulation score 1 -0.57008 0.31308 3.3155 0.0686 0.565 0.306 1.045
UICC CRC 1 1 1.90827 1.24262 2.3583 0.1246 .
UICCCRC 2 1 1.70462 1.24400 1.8777 0.1706 .
UICC CRC 3 1 2.78735 0.94298 8.7373 0.0031 .
UICC CRC 4 1 5.27866 0.83612 39.8576 < .0001 .
UICC BC 1 1 0.38145 1.24018 0.0946 0.7584 .
UICC BC 2 1 0.23170 1.19157 0.0378 0.8458 .
UICC BC 3 1 2.94979 1.28419 5.2763 0.0216 .
UICC BC 4 1 4.11188 0.87876 21.8947 < .0001 .
UICC control 0 00 . . . .
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Figure 2 The Kaplan-Meyer survival function was separately plotted for high and low self-regulation for control, breast cancer and
colorectal cancer patients group.
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ing for the improvement of patients’ self-regulation [31]
and this has been tested in breast cancer prevention
[32] with initial positive findings [15]. There is still a
need for larger prospective observational studies along-
side robust pragmatic trials of interventions based on
the development of self-regulation. Although it has been
reported that the application of mistletoe extracts may
improve the self-regulation and survival of breast cancer
and gynaecological cancer patients [33,34], in this study
we did not find a significant influence of mistletoe
extract application on self-regulation and survival, which
were influenced by operation, chemo- and radiotherapy.
This effect could be due to the high operation rate and
mistletoe baseline application rate and the small sample
size (compare table 1).
Colorectal cancer patients have in comparable stages
with breast cancer patients an inferior survival which is
banal news [35]. In our data CRC patients are more
likely to be in stage III or IV with a relative low che-
motherapy treatment frequency probably because of the
strong complementary therapy desire of these patients
in our centre for integrative medicine and a high mistle-
toe treatment rate etc. The breast cancer group con-
sisted of more long term-survivors. In both cancer
groups UICC stage and grading were strong prognostic
factors alongside self-regulation. In cross-sectional stu-
dies low self-regulation was correlated with higher anxi-
ety, depression and lower HRQL [20]. In a prospective
study, multivariate analysis indicated that self-regulation
can be a cofactor together with autonomic regulation
for anxiety and an independent factor for depression.
Hence, in conclusion, further studies are necessary to
clarify if high self-regulation is an independent influen-
cing factor, or is influenced due to the lack of anxiety,
depression, demoralisation or risk factors. Thus, in the
self-regulation concept we still have to deal with the
same crucial question as for SOC, i.e., whether it is
cause or effect [36].
Studies have measured the impact of disturbed rest/
activity in metastasized colorectal cancer on survival
[7,37] and HRQL [6]. According to meta-analysis, physi-
cal activity stabilizes not only daily activity and rest/
activity rhythm but is actually the treatment with the
highest evidence of improving cancer-related fatigue
[38]. In large tertiary prevention studies it achieves
intensity dependent a relative-risk reduction for colon
and breast carcinoma until 50-57% [39,40]. In metasta-
sized breast cancer, a reduced circadian cortisol rhythm
is associated with higher mortality [8]. These results
principally reflect two aspects: firstly the potential
importance of disturbed circadian rhythm on survival,
and secondly that disturbed and flattened cortisol
rhythm is a distress marker with an influence on
reduced HRQL, higher fatigue level [8] and higher pre-
valence of un-refreshing and disturbed sleep in breast
cancer [41]. Even if there are differences in the fre-
quency of insomnia between breast and colorectal can-
cer [41,42], there is a growing amount of basic research
showing that a disturbed circadian rhythm could play an
important role in malignant growth control in these and
other cancers [43,44]. In spite of unclear underlying
mechanisms, there is growing evidence that disturbed
rest/activity and circadian rhythm are interrelated with
CRF and sleep disturbances in both cancer groups
[5,41,45]. CRF highly correlates with global HRQL and
physical functioning [46] and in face of contradictory
results fatigue, physical and emotional functioning in
breast cancer and global health and particularly social
functioning in colorectal cancer could be prognostic
indictors of survival [47,48]. To clarify if and how
strongly psychometrically measured rest/activity regula-
tion is correlated with actigraphically measured rest/
activity, we are actually conducting two ongoing studies.
In a prospective study we determined that psychometri-
cally measured autonomic regulation is significantly
reducing cancer-related fatigue and cognitive fatigue
[49]. However, the relevance of a disturbed rest/activity
or circadian rhythm in metastasized cancer patients
requires further research and is still unclear in non-
metastasized cancer patients and for the autonomic and
rest/activity regulation measuring questionnaire.
There are several limitations in our study. The study
group is heterogeneously constituted, the time-span
for first diagnosis and study inclusion in particular
has a high variability. Even if we have initial evidence
supported by this data that self-regulation may have
an influence on survival of cancer patients [19], we
need more research with larger samples including suf-
ficient male participants, that allow for every cancer
type a stage adjusted analysis including detailed biolo-
gical prognostic factors and therapies. Furthermore,
rest/activity rhythm should be co-measured
actigraphically.
Conclusions
We have found that self-regulation might be an inde-
pendent prognostic factor for the survival of breast and
colon carcinoma patients. Further prospective studies
with larger populations, more detailed phenotyping of
patients and longer follow-up are required to confirm
this finding. Ultimately we need to test methods to
improve self-regulation in cancer patients as part of
oncological management.
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